SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-030095
Filing Date
2021-05-04
Accepted
2021-05-04 19:21:36
Documents
1
Period of Report
2021-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3965
  Complete submission text file 0001209191-21-030095.txt   5456
Mailing Address C/O TETRAPHASE PHARMACEUTICALS, INC. 480 ARSENAL ST., SUITE 101 WATERTOWN MA 02472
Business Address
Chodakewitz Jeffrey (Reporting) CIK: 0001610876 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38359 | Film No.: 21890522

Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations